Correlation Between Spero Therapeutics and Bioatla

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Spero Therapeutics and Bioatla at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spero Therapeutics and Bioatla into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spero Therapeutics and Bioatla, you can compare the effects of market volatilities on Spero Therapeutics and Bioatla and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spero Therapeutics with a short position of Bioatla. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spero Therapeutics and Bioatla.

Diversification Opportunities for Spero Therapeutics and Bioatla

0.18
  Correlation Coefficient

Average diversification

The 3 months correlation between Spero and Bioatla is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Spero Therapeutics and Bioatla in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bioatla and Spero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spero Therapeutics are associated (or correlated) with Bioatla. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bioatla has no effect on the direction of Spero Therapeutics i.e., Spero Therapeutics and Bioatla go up and down completely randomly.

Pair Corralation between Spero Therapeutics and Bioatla

Given the investment horizon of 90 days Spero Therapeutics is expected to generate 3.61 times less return on investment than Bioatla. But when comparing it to its historical volatility, Spero Therapeutics is 2.65 times less risky than Bioatla. It trades about 0.03 of its potential returns per unit of risk. Bioatla is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  147.00  in Bioatla on August 25, 2024 and sell it today you would earn a total of  10.00  from holding Bioatla or generate 6.8% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Spero Therapeutics  vs.  Bioatla

 Performance 
       Timeline  
Spero Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Spero Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Bioatla 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bioatla has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Spero Therapeutics and Bioatla Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Spero Therapeutics and Bioatla

The main advantage of trading using opposite Spero Therapeutics and Bioatla positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spero Therapeutics position performs unexpectedly, Bioatla can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioatla will offset losses from the drop in Bioatla's long position.
The idea behind Spero Therapeutics and Bioatla pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios